Analgesics in Chile records only marginal growth in 2026 as demand remains constrained by safety concerns surrounding ibuprofen and intensifying price competition from generics. Rather than reflecting expanding consumption, performance is increasingly shaped by share redistribution towards lower-cost alternatives and the growing influence of digital retail. Topical analgesics/anaesthetic provides a rare area of resilience, supported by stable demand for menstrual pain treatments and other recurring pain management needs. The market is becoming increasingly competitive as lower-cost generics gain ground and leading multinational manufacturers gradually lose share. Bayer de Chile SA remains the leading player, but local manufacturers continue strengthening their positions through competitive pricing and broad retail access. At the same time, Mercado Libre's integration of ISP-authorised pharmacies expands online access to regulated pain relief products, increasing price transparency and intensifying competition across the market. Looking ahead, paracetamol is expected to benefit from shifting safety perceptions, while specialised pain relief solutions targeting specific conditions are set to support premium growth. Increasing emphasis on product safety, professional guidance and informed self-medication is expected to reinforce the importance of consumer trust, helping shape future purchasing decisions across the analgesics market.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Chile with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Chile, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Chile report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Chile?
- Which are the leading brands in Analgesics in Chile?
- How are products distributed in Analgesics in Chile?
- How has the regulatory and operating environment for Analgesics changed in Chile?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
E-commerce reshapes access and price competition
Lower-cost alternatives reshape purchasing behaviour
Ibuprofen scrutiny reshapes consumer preferences
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Paracetamol set to benefit from shifting safety perceptions
Specialised pain relief poised to support premium growth
Informed self-medication expected to increase the importance of trust and guidance
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Bayer de Chile retains its lead despite gradual share erosion
Local manufacturers strengthen their presence through affordability and access
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retain their lead through trust and professional guidance
Mercado Libre expands online access to regulated pain relief products
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!